首页 > 最新文献

Patient preference and adherence最新文献

英文 中文
A Qualitative Study on Perspectives of Parkinson’s Disease Medications: Insights from Patient Focus Groups 帕金森病药物观点定性研究:来自患者焦点小组的见解
IF 2.2 3区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-18 DOI: 10.2147/ppa.s473991
Kristin Richards, Sneha Mantri, Carolyn M Brown, Michael Johnsrud, Steve Arcona, Rahul Sasané
Purpose: Medication is an important component of the management of Parkinson’s disease (PD), yet few studies investigate factors that inform medication decision-making from the perspective of those who use these therapies. This qualitative study aimed to better understand the medication experiences and perspectives of people with PD (PwPD).
Patients and Methods: Thirty-two PwPD recruited from five large movement disorder clinics from five US states participated in 1-hour on-line focus groups in 2022. Thematic analysis was used to analyze the data.
Results: Four primary themes (subthemes in parentheses) emerged concerning PD medications: (1) medication effectiveness (uncertainty, inconsistent effects, adjusting expectations); (2) medication burden (morning doses, timing challenges, constant reminder); (3) side effects (toleration, treatment, confusion with disease symptoms); and (4) preferences/requests (important attributes, therapy advancement).
Conclusion: This study identified four core dimensions associated with PD medications from the perspective of PwPD. Results indicate the need for enhanced communication between providers and patients regarding PD medication to reduce the uncertainties and burden associated with PD medication regimens and promote better health outcomes for PwPD.

Keywords: Parkinson’s disease, medication, patient perspective, patient experience
目的:药物治疗是帕金森病(PD)治疗的重要组成部分,但很少有研究从使用这些疗法的患者的角度来调查影响药物治疗决策的因素。这项定性研究旨在更好地了解帕金森病患者(PwPD)的用药经历和观点:2022 年,从美国五个州的五家大型运动障碍诊所招募的 32 名帕金森病患者参加了一个小时的在线焦点小组。采用主题分析法对数据进行分析:出现了与帕金森氏症药物治疗相关的四个主要主题(括号内为次主题):(1)药物治疗效果(不确定性、效果不一致、调整期望值);(2)药物治疗负担(晨起服药、时间挑战、不断提醒);(3)副作用(耐受性、治疗、与疾病症状混淆);以及(4)偏好/要求(重要属性、治疗进展):本研究从残疾人的角度确定了与帕金森病药物治疗相关的四个核心维度。研究结果表明,有必要加强医疗服务提供者与患者之间在帕金森病药物治疗方面的沟通,以减少帕金森病药物治疗方案的不确定性和负担,促进帕金森病患者获得更好的健康结果:帕金森病、药物治疗、患者观点、患者体验
{"title":"A Qualitative Study on Perspectives of Parkinson’s Disease Medications: Insights from Patient Focus Groups","authors":"Kristin Richards, Sneha Mantri, Carolyn M Brown, Michael Johnsrud, Steve Arcona, Rahul Sasané","doi":"10.2147/ppa.s473991","DOIUrl":"https://doi.org/10.2147/ppa.s473991","url":null,"abstract":"<strong>Purpose:</strong> Medication is an important component of the management of Parkinson’s disease (PD), yet few studies investigate factors that inform medication decision-making from the perspective of those who use these therapies. This qualitative study aimed to better understand the medication experiences and perspectives of people with PD (PwPD).<br/><strong>Patients and Methods:</strong> Thirty-two PwPD recruited from five large movement disorder clinics from five US states participated in 1-hour on-line focus groups in 2022. Thematic analysis was used to analyze the data.<br/><strong>Results:</strong> Four primary themes (subthemes in parentheses) emerged concerning PD medications: (1) medication effectiveness (uncertainty, inconsistent effects, adjusting expectations); (2) medication burden (morning doses, timing challenges, constant reminder); (3) side effects (toleration, treatment, confusion with disease symptoms); and (4) preferences/requests (important attributes, therapy advancement).<br/><strong>Conclusion:</strong> This study identified four core dimensions associated with PD medications from the perspective of PwPD. Results indicate the need for enhanced communication between providers and patients regarding PD medication to reduce the uncertainties and burden associated with PD medication regimens and promote better health outcomes for PwPD.<br/><br/><strong>Keywords:</strong> Parkinson’s disease, medication, patient perspective, patient experience<br/>","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"45 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142262133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Network Analysis of Pain Catastrophizing, Self-Efficacy, and Kinesiophobia Among Patients After Total Knee Arthroplasty: A Cross-Sectional Study 全膝关节置换术后患者的疼痛灾难化、自我效能感和运动恐惧网络分析:一项横断面研究
IF 2.2 3区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-16 DOI: 10.2147/ppa.s452773
Yi Zhou, Weina Gao, Zhijiao Cao, Shumin Gao, Xutong Guo, Meng Liu, Congjie Cao
Background: Kinesiophobia is common in patients after total knee arthroplasty and is an important risk factor for post-operative recovery outcomes. Little is known about the complex intercorrelations between different components of pain catastrophizing, self-efficacy, and kinesiophobia. This study aimed to identify the central components of kinesiophobia and to explore the interconnectedness between components of pain catastrophizing, self-efficacy, and kinesiophobia.
Methods: A total of 216 patients after total knee arthroplasty were recruited in this study. Pain Catastrophizing Scale, Self-efficacy of Rehabilitation Outcome Scale and Tampa Scale for Kinesiophobia were used to assess pain catastrophizing, self-efficacy and kinesiophobia. R software was used to visualize the networks and analyze the centrality of the networks. The index “strength” and “bridge expected influence” were employed to identify the central components and the bridge components of the networks.
Results: In the item network of kinesiophobia, three items (“Simply being careful that I do not make any unnecessary movements is the safest thing I can do to prevent my pain from worsening”, “My accident has put my body at risk for the rest of my life”, and “My body is telling me I have something dangerously wrong”) had the highest strength centrality. In the pain catastrophizing/self-efficacy–kinesiophobia network, rumination had the highest positive bridge expected influence, while coping self-efficacy had the highest negative value.
Conclusion: The three central components of kinesiophobia identified in this study, as well as two bridge variables (rumination and coping self-efficacy), could be promising and effective targets for prevention and intervention of kinesiophobia.

背景:运动恐惧在全膝关节置换术后的患者中很常见,是影响术后恢复效果的一个重要风险因素。人们对疼痛灾难化、自我效能感和运动恐惧的不同成分之间复杂的相互关系知之甚少。本研究旨在确定运动恐怖症的核心成分,并探讨疼痛灾难化、自我效能感和运动恐怖症各成分之间的相互联系:本研究共招募了 216 名全膝关节置换术后患者。采用疼痛灾难化量表、康复结果自我效能感量表和运动恐惧坦帕量表来评估疼痛灾难化、自我效能感和运动恐惧。使用 R 软件对网络进行可视化,并分析网络的中心性。采用 "强度 "和 "桥接预期影响 "指标来识别网络的中心成分和桥接成分:结果:在运动恐惧的项目网络中,三个项目("注意不要做任何不必要的动作是防止疼痛恶化的最安全的方法"、"我的事故让我的身体在余生都处于危险之中 "和 "我的身体在告诉我,我出了危险的问题")的强度中心度最高。在疼痛灾难化/自我效能-运动恐惧网络中,反刍具有最高的正桥预期影响,而应对自我效能具有最高的负值:结论:本研究中发现的运动恐怖症的三个中心成分以及两个桥接变量(反刍和应对自我效能感)可以成为预防和干预运动恐怖症的有效目标。
{"title":"Network Analysis of Pain Catastrophizing, Self-Efficacy, and Kinesiophobia Among Patients After Total Knee Arthroplasty: A Cross-Sectional Study","authors":"Yi Zhou, Weina Gao, Zhijiao Cao, Shumin Gao, Xutong Guo, Meng Liu, Congjie Cao","doi":"10.2147/ppa.s452773","DOIUrl":"https://doi.org/10.2147/ppa.s452773","url":null,"abstract":"<strong>Background:</strong> Kinesiophobia is common in patients after total knee arthroplasty and is an important risk factor for post-operative recovery outcomes. Little is known about the complex intercorrelations between different components of pain catastrophizing, self-efficacy, and kinesiophobia. This study aimed to identify the central components of kinesiophobia and to explore the interconnectedness between components of pain catastrophizing, self-efficacy, and kinesiophobia.<br/><strong>Methods:</strong> A total of 216 patients after total knee arthroplasty were recruited in this study. Pain Catastrophizing Scale, Self-efficacy of Rehabilitation Outcome Scale and Tampa Scale for Kinesiophobia were used to assess pain catastrophizing, self-efficacy and kinesiophobia. R software was used to visualize the networks and analyze the centrality of the networks. The index “strength” and “bridge expected influence” were employed to identify the central components and the bridge components of the networks.<br/><strong>Results:</strong> In the item network of kinesiophobia, three items (“Simply being careful that I do not make any unnecessary movements is the safest thing I can do to prevent my pain from worsening”, “My accident has put my body at risk for the rest of my life”, and “My body is telling me I have something dangerously wrong”) had the highest strength centrality. In the pain catastrophizing/self-efficacy–kinesiophobia network, rumination had the highest positive bridge expected influence, while coping self-efficacy had the highest negative value.<br/><strong>Conclusion:</strong> The three central components of kinesiophobia identified in this study, as well as two bridge variables (rumination and coping self-efficacy), could be promising and effective targets for prevention and intervention of kinesiophobia.<br/><br/>","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"118 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142262135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Participation in Medication Safety for Noncommunicable Diseases: A Qualitative Study of General Practitioners, Pharmacists, and Outpatients’ Perspectives in Beijing 患者参与非传染性疾病用药安全:对北京全科医生、药剂师和门诊患者观点的定性研究
IF 2.2 3区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-14 DOI: 10.2147/ppa.s474921
Zhengwen Feng, Hui Li, Xiaolei Chen, Tiancheng Zhang, Yanxiang Chen, Shuang Shao, Juan Du
<strong>Purpose:</strong> Our study aimed to explore the current status of patient participation in medication safety from the perspectives of general practitioners (GPs), pharmacists, and outpatients in Beijing, China.<br/><strong>Patients and Methods:</strong> A qualitative study using semi-structured in-depth individual interviews with GPs, pharmacists, and outpatients. Subjects were identified by purposive sampling until code saturation. Semi-structured qualitative interviews were conducted with GPs, pharmacists, and patients from community health service centers in three urban districts of Beijing, China. The interviews were transcribed verbatim and the text was analysed using thematic analysis techniques including familiarising with data, generating initial codes, searching for themes, reviewing themes, defining and naming themes, and producing the report.<br/><strong>Results:</strong> A total of eight GPs, seven pharmacists, and 18 outpatients were interviewed. Data analysis led to the generation of five key themes: (1) mutual trust between patient and GP, (2) communication with healthcare professionals, (3) acquisition of knowledge about medication safety, (4) implementation of medication self-management at home, and (5) different attitudes toward participation in medication decisions. Patients participated in medication safety in multiple ways. However, insufficient knowledge about medication safety, lack of awareness of the patient’s role in ensuring medication safety, shortage of consultation lengths, and being misled by some information were problems with patient participation in medication safety.<br/><strong>Conclusion:</strong> This exploratory study contributes to our initial understanding of patient participation in medication safety. There were still many issues and barriers in the process of patient participation. Appropriate policies and measures, such as providing various forms of patient education, ensuring sufficient physician-patient communication, giving full play to the role of pharmacists, and making judicious use of digital health tools should be taken to improve medication safety by fully utilising the role of patients.<br/><br/><strong>Plain Language Summary:</strong> Medication safety is a significant concern around the world. Patient participation in the medication process is effective in reducing the incidence of medication errors and improving medication safety. However, the role of outpatients with chronic conditions in ensuring medication safety is often neglected. This study aims to explore the perspectives and experiences of GPs, pharmacists, and outpatients by qualitative interviews in Beijing, China. The study involved a series of interviews with eight GPs, seven pharmacists, and 18 outpatients living with noncommunicable diseases. The interview revealed five themes: (1) mutual trust between patient and GP, (2) communication with healthcare professionals, (3) acquisition of knowledge about medication safety
目的:我们的研究旨在从中国北京的全科医生(GP)、药剂师和门诊患者的角度探讨患者参与用药安全的现状:对全科医生、药剂师和门诊患者进行半结构化的深入访谈。研究对象通过有目的的抽样确定,直至代码饱和。对中国北京三个城区的社区卫生服务中心的全科医生、药剂师和患者进行了半结构化定性访谈。访谈内容被逐字誊写,并使用主题分析技术对文本进行分析,包括熟悉数据、生成初始代码、搜索主题、审查主题、定义和命名主题以及制作报告:共采访了 8 名全科医生、7 名药剂师和 18 名门诊患者。数据分析产生了五个关键主题:(1) 患者与全科医生之间的相互信任;(2) 与医护人员的沟通;(3) 掌握用药安全知识;(4) 在家中实施用药自我管理;(5) 对参与用药决策的不同态度。患者以多种方式参与用药安全。然而,用药安全知识不足、对患者在确保用药安全中的作用缺乏认识、咨询时间不足以及被某些信息误导是患者参与用药安全的问题所在:这项探索性研究有助于我们初步了解患者参与用药安全的情况。患者参与过程中仍存在许多问题和障碍。应采取适当的政策和措施,如提供多种形式的患者教育、确保充分的医患沟通、充分发挥药剂师的作用、合理使用数字医疗工具等,充分发挥患者的作用,提高用药安全。患者参与用药过程可有效降低用药错误发生率,提高用药安全性。然而,门诊慢性病患者在确保用药安全方面的作用往往被忽视。本研究旨在通过在中国北京进行定性访谈,探讨全科医生、药剂师和门诊患者的观点和经验。研究对 8 名全科医生、7 名药剂师和 18 名门诊非传染性疾病患者进行了一系列访谈。访谈揭示了五个主题:(1)患者与全科医生之间的相互信任;(2)与医护人员的沟通;(3)掌握用药安全知识;(4)在家中实施用药自我管理;(5)对参与用药决策的不同态度。这些发现可能有助于为患者参与用药安全提出建议。将这些研究结果纳入今后的研究中,有助于医护人员制定干预措施,更好地支持患者参与用药过程。关键词:用药安全;患者参与;患者安全;定性研究;非传染性疾病;社区卫生服务中心
{"title":"Patient Participation in Medication Safety for Noncommunicable Diseases: A Qualitative Study of General Practitioners, Pharmacists, and Outpatients’ Perspectives in Beijing","authors":"Zhengwen Feng, Hui Li, Xiaolei Chen, Tiancheng Zhang, Yanxiang Chen, Shuang Shao, Juan Du","doi":"10.2147/ppa.s474921","DOIUrl":"https://doi.org/10.2147/ppa.s474921","url":null,"abstract":"&lt;strong&gt;Purpose:&lt;/strong&gt; Our study aimed to explore the current status of patient participation in medication safety from the perspectives of general practitioners (GPs), pharmacists, and outpatients in Beijing, China.&lt;br/&gt;&lt;strong&gt;Patients and Methods:&lt;/strong&gt; A qualitative study using semi-structured in-depth individual interviews with GPs, pharmacists, and outpatients. Subjects were identified by purposive sampling until code saturation. Semi-structured qualitative interviews were conducted with GPs, pharmacists, and patients from community health service centers in three urban districts of Beijing, China. The interviews were transcribed verbatim and the text was analysed using thematic analysis techniques including familiarising with data, generating initial codes, searching for themes, reviewing themes, defining and naming themes, and producing the report.&lt;br/&gt;&lt;strong&gt;Results:&lt;/strong&gt; A total of eight GPs, seven pharmacists, and 18 outpatients were interviewed. Data analysis led to the generation of five key themes: (1) mutual trust between patient and GP, (2) communication with healthcare professionals, (3) acquisition of knowledge about medication safety, (4) implementation of medication self-management at home, and (5) different attitudes toward participation in medication decisions. Patients participated in medication safety in multiple ways. However, insufficient knowledge about medication safety, lack of awareness of the patient’s role in ensuring medication safety, shortage of consultation lengths, and being misled by some information were problems with patient participation in medication safety.&lt;br/&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; This exploratory study contributes to our initial understanding of patient participation in medication safety. There were still many issues and barriers in the process of patient participation. Appropriate policies and measures, such as providing various forms of patient education, ensuring sufficient physician-patient communication, giving full play to the role of pharmacists, and making judicious use of digital health tools should be taken to improve medication safety by fully utilising the role of patients.&lt;br/&gt;&lt;br/&gt;&lt;strong&gt;Plain Language Summary:&lt;/strong&gt; Medication safety is a significant concern around the world. Patient participation in the medication process is effective in reducing the incidence of medication errors and improving medication safety. However, the role of outpatients with chronic conditions in ensuring medication safety is often neglected. This study aims to explore the perspectives and experiences of GPs, pharmacists, and outpatients by qualitative interviews in Beijing, China. The study involved a series of interviews with eight GPs, seven pharmacists, and 18 outpatients living with noncommunicable diseases. The interview revealed five themes: (1) mutual trust between patient and GP, (2) communication with healthcare professionals, (3) acquisition of knowledge about medication safety","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"21 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142262134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Gender on Patient Experiences of Self-Management in Type 2 Diabetes: A Qualitative Study 性别对 2 型糖尿病患者自我管理体验的影响:定性研究
IF 2.2 3区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-13 DOI: 10.2147/ppa.s466931
Anna Ramírez-Morros, Anna Berenguera, Laura Millaruelo, Pilar Buil-Cosiales, Carmen Gomez Garcia, Xavier Cos, Luis Ávila Lachica, Sara Artola, Jose Manuel Millaruelo, Didac Mauricio, Josep Franch-Nadal
Purpose: This study aims to identify gender disparities in knowledge, attitudes and behaviors related to self-management and control of Type 2 diabetes Mellitus (T2DM) among primary care patients. The research was conducted across multiple Spanish cities.
Patients and Methods: The study involved 8 Primary Care Centres located in four distinct regions of Spain: East (Barcelona), Centre (Madrid), North (Pamplona and Zumaia) and South (Vélez-Málaga and Málaga). A total of 111 individuals diagnosed with T2DM, comprising 52 women and 59 men, participated in 12 group discussions at these primary healthcare centers from February to June 2015. Participation was voluntary, and all participants provided informed consent by signing the consent form. A qualitative hermeneutic phenomenological study with a maximum variation sample was done. Participant profiles were defined based on gender, age, place of residence, type of treatment, years living with T2DM and the presence or absence of a cardiovascular event. Thematic analysis was used to analyze the data.
Results: Participants were aware that diabetes is a chronic condition, with varied levels of concern regarding the diagnosis. Participants’ locus of control influenced their perception of the disease’s cause, with women attributing it to stress and emotional situations, while men linked it to risky behaviors. Self-management strategies were shaped by beliefs about diabetes, with both genders facing challenges in implementing recommended practices. Gender differences were also evident in caregiving roles, with men receiving more family support for diet adherence, while women prioritized family needs over their self-care. Participants expressed satisfaction with professional-patient interactions but highlighted the need for more accessible information and specialist care, suggesting support groups for women and clear health guidelines for men.
Conclusion: Gender differences significantly influence how patients perceive and manage type 2 diabetes, with women experiencing greater concern and care burden compared to men. Effective diabetes management requires tailored support that addresses these gender-specific challenges. Enhancing healthcare services with clear guidelines and support groups can improve self-management outcomes in both men and women.

Keywords: gender, type 2 diabetes mellitus, self-care, personal experience
目的:本研究旨在确定初级保健患者在自我管理和控制 2 型糖尿病(T2DM)的相关知识、态度和行为方面的性别差异。研究在西班牙多个城市进行:研究涉及西班牙四个不同地区的 8 个初级保健中心:东部(巴塞罗那)、中部(马德里)、北部(潘普洛纳和祖马亚)和南部(贝莱斯-马拉加和马拉加)。2015年2月至6月期间,共有111名被诊断患有T2DM的患者参加了在这些初级医疗保健中心举行的12次小组讨论,其中包括52名女性和59名男性。所有参与者均自愿参加,并在知情同意书上签字。研究采用定性诠释现象学研究方法,样本变化最大。根据性别、年龄、居住地、治疗类型、患有 T2DM 的年数以及是否发生过心血管事件对参与者进行了界定。数据分析采用主题分析法:结果:参与者意识到糖尿病是一种慢性疾病,但对诊断的关注程度各不相同。参与者的控制感影响了他们对病因的认识,女性将其归因于压力和情绪状况,而男性则将其与危险行为联系在一起。自我管理策略受糖尿病信念的影响,两性在实施推荐做法时都面临挑战。性别差异在护理角色方面也很明显,男性在坚持饮食方面得到了更多的家庭支持,而女性则将家庭需求置于自我护理之上。参与者对专业人员与患者之间的互动表示满意,但强调需要更多的信息和专家护理,建议为女性设立支持小组,为男性制定明确的健康指南:结论:性别差异在很大程度上影响着患者对 2 型糖尿病的认识和管理,与男性相比,女性的担忧和护理负担更大。有效的糖尿病管理需要有针对性的支持,以应对这些因性别而异的挑战。通过明确的指南和支持小组来加强医疗保健服务,可以改善男性和女性的自我管理结果。
{"title":"Impact of Gender on Patient Experiences of Self-Management in Type 2 Diabetes: A Qualitative Study","authors":"Anna Ramírez-Morros, Anna Berenguera, Laura Millaruelo, Pilar Buil-Cosiales, Carmen Gomez Garcia, Xavier Cos, Luis Ávila Lachica, Sara Artola, Jose Manuel Millaruelo, Didac Mauricio, Josep Franch-Nadal","doi":"10.2147/ppa.s466931","DOIUrl":"https://doi.org/10.2147/ppa.s466931","url":null,"abstract":"<strong>Purpose:</strong> This study aims to identify gender disparities in knowledge, attitudes and behaviors related to self-management and control of Type 2 diabetes Mellitus (T2DM) among primary care patients. The research was conducted across multiple Spanish cities.<br/><strong>Patients and Methods:</strong> The study involved 8 Primary Care Centres located in four distinct regions of Spain: East (Barcelona), Centre (Madrid), North (Pamplona and Zumaia) and South (Vélez-Málaga and Málaga). A total of 111 individuals diagnosed with T2DM, comprising 52 women and 59 men, participated in 12 group discussions at these primary healthcare centers from February to June 2015. Participation was voluntary, and all participants provided informed consent by signing the consent form. A qualitative hermeneutic phenomenological study with a maximum variation sample was done. Participant profiles were defined based on gender, age, place of residence, type of treatment, years living with T2DM and the presence or absence of a cardiovascular event. Thematic analysis was used to analyze the data.<br/><strong>Results:</strong> Participants were aware that diabetes is a chronic condition, with varied levels of concern regarding the diagnosis. Participants’ locus of control influenced their perception of the disease’s cause, with women attributing it to stress and emotional situations, while men linked it to risky behaviors. Self-management strategies were shaped by beliefs about diabetes, with both genders facing challenges in implementing recommended practices. Gender differences were also evident in caregiving roles, with men receiving more family support for diet adherence, while women prioritized family needs over their self-care. Participants expressed satisfaction with professional-patient interactions but highlighted the need for more accessible information and specialist care, suggesting support groups for women and clear health guidelines for men.<br/><strong>Conclusion:</strong> Gender differences significantly influence how patients perceive and manage type 2 diabetes, with women experiencing greater concern and care burden compared to men. Effective diabetes management requires tailored support that addresses these gender-specific challenges. Enhancing healthcare services with clear guidelines and support groups can improve self-management outcomes in both men and women.<br/><br/><strong>Keywords:</strong> gender, type 2 diabetes mellitus, self-care, personal experience<br/>","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"83 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142204046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of the Healthcare-Seeking Intention Questionnaire in Patients with Diabetic High-Risk Foot 糖尿病高危足患者就医意向问卷的开发与验证
IF 2.2 3区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-12 DOI: 10.2147/ppa.s479644
Honglin Wang, Na Li, Ying Ye, Nan Zhao, Meizi Liu, Min Xu, Qiuhong Zhou
Objective: Timely screening and intervention can prevent the development of the diabetic foot. However, delayed visits to the clinic are common among diabetic foot patients. The study aimed to develop and validate a questionnaire to assess healthcare-seeking behavior among patients with diabetic high-risk foot.
Methods: The questionnaire of healthcare-seeking intention for patients with diabetic high-risk foot was developed in two phases: (1) Developing the questionnaire: 1) questionnaire items were formulated after literature review, group discussion and semi-qualitative interview; 2) a two-round modified Delphi method was to examine the content validity and the degree of consistency in questionnaire items; 3) conducting pre-survey to revise the questionnaire items. (2) Assessing the internal reliability and construct validity.
Results: The final questionnaire consisted of five main themes and 28 items with a five-point rating. Cronbach’s alpha coefficients for the five dimensions were respectively 0.937 (relevant knowledge of diabetic foot), 0.669 (attitudes toward seeking care), 0.896 (social support for seeking care), 0.621 (efficacy in coping with foot symptoms), 0.871 (intention to seek care). The Scale-level Content Validity Index of the five parts was 1.00, 0.80, 1.00, 1.00, and 1.00, respectively. The Kaiser-Meyer-Olkin values for each dimension was greater than 0.7, and the p-value for Bartlett’s test of sphericity was less than 0.05.
Conclusion: This questionnaire showed good validity, internal consistency, and reliability. It provided a potentially useful instrument to evaluate healthcare-seeking intention among patients with diabetic high-risk foot.

Keywords: healthcare-seeking intention, questionnaire development, high-risk foot, patients
目的:及时筛查和干预可以预防糖尿病足的发生。然而,糖尿病足患者普遍存在延迟就诊的现象。本研究旨在开发并验证一份问卷,以评估糖尿病足高危患者的就医行为:糖尿病足高危患者就医意向问卷的编制分为两个阶段:(1)编制问卷:1)通过文献查阅、小组讨论、半定性访谈等方法制定问卷题项;2)采用两轮修正德尔菲法检验问卷题项的内容效度和一致性;3)进行预调查,修订问卷题项。(结果:最终问卷包括五大主题和 28 个项目,采用五点评分法。五个维度的 Cronbach's alpha 系数分别为 0.937(糖尿病足相关知识)、0.669(求医态度)、0.896(求医的社会支持)、0.621(应对足部症状的效能)和 0.871(求医意向)。五个部分的量表级内容效度指数分别为 1.00、0.80、1.00、1.00 和 1.00。各维度的 Kaiser-Meyer-Olkin 值均大于 0.7,Bartlett 球形度检验的 p 值小于 0.05:该问卷具有良好的效度、内部一致性和信度。关键词:就医意向;问卷编制;高危足;患者
{"title":"Development and Validation of the Healthcare-Seeking Intention Questionnaire in Patients with Diabetic High-Risk Foot","authors":"Honglin Wang, Na Li, Ying Ye, Nan Zhao, Meizi Liu, Min Xu, Qiuhong Zhou","doi":"10.2147/ppa.s479644","DOIUrl":"https://doi.org/10.2147/ppa.s479644","url":null,"abstract":"<strong>Objective:</strong> Timely screening and intervention can prevent the development of the diabetic foot. However, delayed visits to the clinic are common among diabetic foot patients. The study aimed to develop and validate a questionnaire to assess healthcare-seeking behavior among patients with diabetic high-risk foot.<br/><strong>Methods:</strong> The questionnaire of healthcare-seeking intention for patients with diabetic high-risk foot was developed in two phases: (1) Developing the questionnaire: 1) questionnaire items were formulated after literature review, group discussion and semi-qualitative interview; 2) a two-round modified Delphi method was to examine the content validity and the degree of consistency in questionnaire items; 3) conducting pre-survey to revise the questionnaire items. (2) Assessing the internal reliability and construct validity.<br/><strong>Results:</strong> The final questionnaire consisted of five main themes and 28 items with a five-point rating. Cronbach’s alpha coefficients for the five dimensions were respectively 0.937 (relevant knowledge of diabetic foot), 0.669 (attitudes toward seeking care), 0.896 (social support for seeking care), 0.621 (efficacy in coping with foot symptoms), 0.871 (intention to seek care). The Scale-level Content Validity Index of the five parts was 1.00, 0.80, 1.00, 1.00, and 1.00, respectively. The Kaiser-Meyer-Olkin values for each dimension was greater than 0.7, and the p-value for Bartlett’s test of sphericity was less than 0.05.<br/><strong>Conclusion:</strong> This questionnaire showed good validity, internal consistency, and reliability. It provided a potentially useful instrument to evaluate healthcare-seeking intention among patients with diabetic high-risk foot.<br/><br/><strong>Keywords:</strong> healthcare-seeking intention, questionnaire development, high-risk foot, patients<br/>","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"14 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142204047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Description of Feelings, Perception, and Experience Before and After Switching from IV Daratumumab to the SC Form: A Mixed-Method, Cross-Sectional Survey in Multiple Myeloma Patients in Europe 欧洲多发性骨髓瘤患者从静脉注射达拉曲单抗转为静脉注射达拉曲单抗前后的感受、认知和体验描述:欧洲多发性骨髓瘤患者的混合方法横断面调查
IF 2.2 3区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-10 DOI: 10.2147/ppa.s453920
Valeria Magarotto, Julien Thevenon, Kate Morgan, Silene ten Seldam, Wafae Iraqi, Xavier Guillaume, Marjorie Leclerc, Claire Graziani-Taugeron, Bleuenn Rault, Dahbia Horchi
Purpose: To provide real-world data on patient perceptions and experiences with subcutaneous (SC) versus intravenous (IV) daratumumab.
Patients and Methods: This was a cross-sectional, mixed-method (qualitative/quantitative) survey conducted in France, Germany, Spain and the United Kingdom involving multiple myeloma (MM) patients who switched from IV to SC daratumumab in the last 12 months (qualitative phase) or 24 months (quantitative phase [26 months in the UK]) prior to enrollment in the study.
Results: Nine patients (mean age 65 years) participated in the qualitative phase and 113 patients (mean age 65.1 years) in the quantitative phase. Qualitative study results provided insights for the quantitative study and highlighted the benefits of switching from daratumumab IV to daratumumab SC as an improvement and a satisfactory change in patients’ treatment journey. Quantitative survey showed that patients were significantly less anxious, stressed and nervous before SC injections than IV infusions (mean score: 1.3, 1.1, 1.4 versus 2.1, 2.0, 2.0 respectively, p< 0.001), and significantly more reassured, ready/well-prepared, usual self and relieved (mean score: 3.8, 4.3, 3.7, 3.6 versus 3.0, 3.6, 3.1, 3.0 respectively, p< 0.001). Immediately after SC first injection, 96.5% patients were feeling well or very well versus 77.9% immediately after IV first infusion (p< 0.001). 97.3% patients were satisfied with their SC treatment versus 89.4% for the IV injection (p< 0.001). Patients spent significantly less time in hospital for an SC injection of daratumumab than for an IV infusion, 1.5 hours and 5.0 hours respectively (p< 0.001). In the UK, the differences between the two administration forms were less visible, likely because of confounding factors including a longer time passed since the switch from the IV to the SC form and administration of the survey.
Conclusion: In line with results from other studies, the SC form of daratumumab had less impact on patients’ emotional burden than the IV form.

Keywords: multiple myeloma, daratumumab, mode of administration, patients’ emotional burden, mixed method
目的:提供患者对皮下注射(SC)达拉单抗与静脉注射(IV)达拉单抗的看法和体验的真实世界数据:这是一项在法国、德国、西班牙和英国进行的横断面混合方法(定性/定量)调查,涉及在加入研究前12个月(定性阶段)或24个月(定量阶段[英国为26个月])内从静脉注射达拉单抗转为皮下注射达拉单抗的多发性骨髓瘤(MM)患者:9名患者(平均年龄65岁)参加了定性研究,113名患者(平均年龄65.1岁)参加了定量研究。定性研究结果为定量研究提供了启示,并强调了从daratumumab静脉滴注转为daratumumab SC治疗的益处,认为这是患者治疗过程中的一种改进和令人满意的改变。定量调查显示,与静脉注射相比,患者在SC注射前的焦虑、压力和紧张程度明显降低(平均得分:分别为1.3、1.1、1.4对2.1、2.0、2.0,p< 0.001),而安心、准备好/准备充分、通常的自我和放松程度明显提高(平均得分:分别为3.8、4.3、3.7、3.6对3.0、3.6、3.1、3.0,p< 0.001)。首次皮下注射后,96.5% 的患者感觉良好或非常好,而首次静脉注射后,77.9% 的患者感觉良好或非常好(p< 0.001)。97.3%的患者对皮下注射治疗感到满意,而静脉注射的满意度为 89.4%(p< 0.001)。患者在医院接受达拉单抗皮下注射的时间明显少于静脉输注,分别为1.5小时和5.0小时(p< 0.001)。在英国,两种给药形式之间的差异不太明显,这可能是由于从静脉输注转为皮下注射的时间较长以及进行调查等混杂因素造成的:关键词:多发性骨髓瘤;达拉单抗;给药方式;患者情绪负担;混合法
{"title":"Description of Feelings, Perception, and Experience Before and After Switching from IV Daratumumab to the SC Form: A Mixed-Method, Cross-Sectional Survey in Multiple Myeloma Patients in Europe","authors":"Valeria Magarotto, Julien Thevenon, Kate Morgan, Silene ten Seldam, Wafae Iraqi, Xavier Guillaume, Marjorie Leclerc, Claire Graziani-Taugeron, Bleuenn Rault, Dahbia Horchi","doi":"10.2147/ppa.s453920","DOIUrl":"https://doi.org/10.2147/ppa.s453920","url":null,"abstract":"<strong>Purpose:</strong> To provide real-world data on patient perceptions and experiences with subcutaneous (SC) versus intravenous (IV) daratumumab.<br/><strong>Patients and Methods:</strong> This was a cross-sectional, mixed-method (qualitative/quantitative) survey conducted in France, Germany, Spain and the United Kingdom involving multiple myeloma (MM) patients who switched from IV to SC daratumumab in the last 12 months (qualitative phase) or 24 months (quantitative phase [26 months in the UK]) prior to enrollment in the study.<br/><strong>Results:</strong> Nine patients (mean age 65 years) participated in the qualitative phase and 113 patients (mean age 65.1 years) in the quantitative phase. Qualitative study results provided insights for the quantitative study and highlighted the benefits of switching from daratumumab IV to daratumumab SC as an improvement and a satisfactory change in patients’ treatment journey. Quantitative survey showed that patients were significantly less anxious, stressed and nervous before SC injections than IV infusions (mean score: 1.3, 1.1, 1.4 versus 2.1, 2.0, 2.0 respectively, p&lt; 0.001), and significantly more reassured, ready/well-prepared, usual self and relieved (mean score: 3.8, 4.3, 3.7, 3.6 versus 3.0, 3.6, 3.1, 3.0 respectively, p&lt; 0.001). Immediately after SC first injection, 96.5% patients were feeling well or very well versus 77.9% immediately after IV first infusion (p&lt; 0.001). 97.3% patients were satisfied with their SC treatment versus 89.4% for the IV injection (p&lt; 0.001). Patients spent significantly less time in hospital for an SC injection of daratumumab than for an IV infusion, 1.5 hours and 5.0 hours respectively (p&lt; 0.001). In the UK, the differences between the two administration forms were less visible, likely because of confounding factors including a longer time passed since the switch from the IV to the SC form and administration of the survey.<br/><strong>Conclusion:</strong> In line with results from other studies, the SC form of daratumumab had less impact on patients’ emotional burden than the IV form.<br/><br/><strong>Keywords:</strong> multiple myeloma, daratumumab, mode of administration, patients’ emotional burden, mixed method<br/>","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"22 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142204069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations 澳大利亚社区 2 型糖尿病患者代谢功能障碍相关性脂肪肝护理路径:障碍与考虑因素
IF 2.2 3区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-09 DOI: 10.2147/ppa.s468705
Lucy Gracen, Melanie Aikebuse, Babak Sarraf, Steven M McPhail, Anthony W Russell, James O’Beirne, Katharine M Irvine, Suzanne Williams, Patricia C Valery, Elizabeth E Powell
Background: Although clinical guidelines endorse screening for metabolic dysfunction-associated steatotic liver disease (MASLD) with advanced fibrosis in people with type 2 diabetes (T2D), the feasibility of and barriers and considerations relevant to implementing this approach in the community remain unclear.
Methods: Sequential adults with T2D attending selected community clinics during 2021– 2023 were invited to receive a “liver health check” (n=543). A further 95 participants were referred directly from their general practitioner (GP) or self-referred to the study. A total of 302 participants underwent a point of care assessment of hepatic steatosis and stiffness (FibroScan) and were advised to see their GP to discuss the results. “Template” letters containing key results, their interpretation and advice about management of cardiometabolic risk, patient follow-up and referral criteria, were sent to participants’ GPs.
Results: Referral to a tertiary liver clinic was advised in GP letters for 45 (15%) participants with an increased risk of clinically significant fibrosis (liver stiffness measurement ≥ 8), 15 participants with ‘red flags’ (eg splenomegaly, thrombocytopenia) and 2 with unsuccessful FibroScan examinations. A referral from GPs to the liver clinic was received for 27 (44%) of these 62 participants. Approximately 90% of GPs rated the “template” letters favourably on a Likert rating scale.
Conclusion: The low rate of participation in the “liver health check” and liver clinic referral reflects a real-world scenario and may stem from societal under-recognition and engagement with MASLD, competing health priorities or under-appreciation of the link between liver fibrosis severity and mortality risk. Further studies need to address strategies to enhance participation in liver health assessments and determine their impact on liver-related morbidity/mortality and overall survival.

背景:尽管临床指南认可对2型糖尿病(T2D)患者进行伴有晚期纤维化的代谢功能障碍相关性脂肪性肝病(MASLD)筛查,但在社区实施这种方法的可行性、障碍和注意事项仍不清楚:方法:2021-2023年期间,在选定社区诊所就诊的T2D成人患者被邀请接受 "肝脏健康检查"(543人)。另有95名参与者由其全科医生(GP)直接转介或自我转介至本研究。共有 302 名参与者接受了肝脂肪变性和肝硬变(纤维扫描)的护理点评估,并被建议去看全科医生以讨论结果。向参与者的全科医生发送了 "模板 "信件,其中包含主要结果、对结果的解释以及有关心脏代谢风险的管理、患者随访和转诊标准的建议:结果:全科医生信中建议将45名(15%)临床显著纤维化风险增加的参与者(肝脏硬度测量值≥8)、15名出现 "红旗"(如脾脏肿大、血小板减少)的参与者和2名纤维扫描检查不成功的参与者转诊至三级肝脏诊所。在这 62 名参与者中,有 27 人(44%)由全科医生转介到肝病诊所。约 90% 的全科医生对 "模板 "信件给予了好评:参与 "肝脏健康检查 "和肝脏门诊转诊的比例较低,这反映了现实世界中的情况,可能是由于社会对MASLD的认识和参与不足、健康优先事项相互竞争或对肝纤维化严重程度与死亡风险之间的联系认识不足。进一步的研究需要探讨加强参与肝脏健康评估的策略,并确定其对肝脏相关发病率/死亡率和总生存率的影响。
{"title":"An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations","authors":"Lucy Gracen, Melanie Aikebuse, Babak Sarraf, Steven M McPhail, Anthony W Russell, James O’Beirne, Katharine M Irvine, Suzanne Williams, Patricia C Valery, Elizabeth E Powell","doi":"10.2147/ppa.s468705","DOIUrl":"https://doi.org/10.2147/ppa.s468705","url":null,"abstract":"<strong>Background:</strong> Although clinical guidelines endorse screening for metabolic dysfunction-associated steatotic liver disease (MASLD) with advanced fibrosis in people with type 2 diabetes (T2D), the feasibility of and barriers and considerations relevant to implementing this approach in the community remain unclear.<br/><strong>Methods:</strong> Sequential adults with T2D attending selected community clinics during 2021– 2023 were invited to receive a “liver health check” (n=543). A further 95 participants were referred directly from their general practitioner (GP) or self-referred to the study. A total of 302 participants underwent a point of care assessment of hepatic steatosis and stiffness (FibroScan) and were advised to see their GP to discuss the results. “Template” letters containing key results, their interpretation and advice about management of cardiometabolic risk, patient follow-up and referral criteria, were sent to participants’ GPs.<br/><strong>Results:</strong> Referral to a tertiary liver clinic was advised in GP letters for 45 (15%) participants with an increased risk of clinically significant fibrosis (liver stiffness measurement ≥ 8), 15 participants with ‘red flags’ (eg splenomegaly, thrombocytopenia) and 2 with unsuccessful FibroScan examinations. A referral from GPs to the liver clinic was received for 27 (44%) of these 62 participants. Approximately 90% of GPs rated the “template” letters favourably on a Likert rating scale.<br/><strong>Conclusion:</strong> The low rate of participation in the “liver health check” and liver clinic referral reflects a real-world scenario and may stem from societal under-recognition and engagement with MASLD, competing health priorities or under-appreciation of the link between liver fibrosis severity and mortality risk. Further studies need to address strategies to enhance participation in liver health assessments and determine their impact on liver-related morbidity/mortality and overall survival.<br/><br/>","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"15 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142204070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Educational Interventions for Individuals with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review 针对接受胰岛素治疗的 2 型糖尿病患者的教育干预:系统回顾
IF 2.2 3区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-07 DOI: 10.2147/ppa.s482882
Chontira Riangkam, Suebsarn Ruksakulpiwat, Pawitra Jariyasakulwong, Varaporn Panichpathom, Lalipat Phianhasin
Objective: To evaluate and synthesize evidence on the impact of educational interventions for individuals with insulin-treated type 2 diabetes mellitus (T2DM).
Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, five electronic databases (Scopus, PubMed, Medline, CINAHL Plus with Full Text, and Web of Science) were systematically searched in February 2024. The search focused on studies published between 2019 and 2024 that investigated the impact of educational interventions on individuals with insulin-treated T2DM. Reference lists of the included studies were also manually searched. Titles and abstracts were screened for eligibility, and relevant full texts were assessed.
Results: Out of 1,032 identified records, 11 studies met the inclusion criteria. According to the data synthesized using a convergent integrated analysis framework, five major themes have emerged: 1) Glycemic control (including subthemes improving HbA1C, decreasing postprandial plasma glucose, and decreasing fasting plasma glucose), 2) Insulin-related complications (including subthemes reducing hypoglycemic events and reducing the size of lipohypertrophy), 3) Knowledge, Attitude, and Practice (including subthemes engaging in self-management, improving insulin injection technique, improving knowledge, and improving attitude toward insulin treatment), 4) Optimal dose of insulin, and 5) Improving quality of life.
Conclusion: Educational interventions are crucial for improving diabetes-related outcomes and reducing complications in individuals with insulin-treated T2DM. These interventions enhance knowledge, attitudes, and self-management practices, leading to better glycemic control and quality of life. Healthcare settings should develop and provide tailored educational programs for individuals with insulin-treated T2DM to optimize outcomes and minimize complications.

Keywords: type 2 diabetes, insulin-treated, education, health management
目的评估并综合有关教育干预对接受胰岛素治疗的 2 型糖尿病患者(T2DM)的影响的证据:按照系统综述和元分析首选报告项目(PRISMA)指南,在 2024 年 2 月对五个电子数据库(Scopus、PubMed、Medline、CINAHL Plus with Full Text 和 Web of Science)进行了系统检索。检索的重点是 2019 年至 2024 年间发表的研究,这些研究调查了教育干预对接受胰岛素治疗的 T2DM 患者的影响。还人工检索了纳入研究的参考文献列表。对标题和摘要进行了资格筛选,并对相关全文进行了评估:在已确认的 1,032 条记录中,有 11 项研究符合纳入标准。根据使用聚合综合分析框架进行的数据综合,得出了五大主题:1)血糖控制(包括改善 HbA1C、降低餐后血浆葡萄糖和降低空腹血浆葡萄糖等副主题);2)胰岛素相关并发症(包括减少低血糖事件和缩小脂肪肥厚等副主题);3)知识、态度和实践(包括参与自我管理、改善胰岛素注射技术、提高知识水平和改善胰岛素治疗态度等副主题);4)胰岛素的最佳剂量;5)提高生活质量。结论教育干预对于改善胰岛素治疗 T2DM 患者的糖尿病相关预后和减少并发症至关重要。这些干预措施能增强患者的知识、态度和自我管理实践,从而改善血糖控制和生活质量。医疗机构应为胰岛素治疗的T2DM患者制定和提供量身定制的教育计划,以优化治疗效果和减少并发症。
{"title":"Educational Interventions for Individuals with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review","authors":"Chontira Riangkam, Suebsarn Ruksakulpiwat, Pawitra Jariyasakulwong, Varaporn Panichpathom, Lalipat Phianhasin","doi":"10.2147/ppa.s482882","DOIUrl":"https://doi.org/10.2147/ppa.s482882","url":null,"abstract":"<strong>Objective:</strong> To evaluate and synthesize evidence on the impact of educational interventions for individuals with insulin-treated type 2 diabetes mellitus (T2DM).<br/><strong>Methods:</strong> Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, five electronic databases (Scopus, PubMed, Medline, CINAHL Plus with Full Text, and Web of Science) were systematically searched in February 2024. The search focused on studies published between 2019 and 2024 that investigated the impact of educational interventions on individuals with insulin-treated T2DM. Reference lists of the included studies were also manually searched. Titles and abstracts were screened for eligibility, and relevant full texts were assessed.<br/><strong>Results:</strong> Out of 1,032 identified records, 11 studies met the inclusion criteria. According to the data synthesized using a convergent integrated analysis framework, five major themes have emerged: 1) Glycemic control (including subthemes improving HbA1C, decreasing postprandial plasma glucose, and decreasing fasting plasma glucose), 2) Insulin-related complications (including subthemes reducing hypoglycemic events and reducing the size of lipohypertrophy), 3) Knowledge, Attitude, and Practice (including subthemes engaging in self-management, improving insulin injection technique, improving knowledge, and improving attitude toward insulin treatment), 4) Optimal dose of insulin, and 5) Improving quality of life.<br/><strong>Conclusion:</strong> Educational interventions are crucial for improving diabetes-related outcomes and reducing complications in individuals with insulin-treated T2DM. These interventions enhance knowledge, attitudes, and self-management practices, leading to better glycemic control and quality of life. Healthcare settings should develop and provide tailored educational programs for individuals with insulin-treated T2DM to optimize outcomes and minimize complications.<br/><br/><strong>Keywords:</strong> type 2 diabetes, insulin-treated, education, health management<br/>","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"2 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142204073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Motivation and Barriers to Postoperative Rehabilitation Exercise in Type 2 Diabetic Patients with Rotator Cuff Injuries: A Qualitative Study [Letter] 肩袖损伤的 2 型糖尿病患者术后康复锻炼的动机和障碍:定性研究 [信函]
IF 2.2 3区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-06 DOI: 10.2147/ppa.s494075
Zhanshuo Xiao, Yilin Jiang, Narina A Samah
Letter for the article Motivation and Barriers to Postoperative Rehabilitation Exercise in Type 2 Diabetic Patients with Rotator Cuff Injuries: A Qualitative Study
致信《肩袖损伤的 2 型糖尿病患者术后康复锻炼的动机和障碍》一文:定性研究
{"title":"Motivation and Barriers to Postoperative Rehabilitation Exercise in Type 2 Diabetic Patients with Rotator Cuff Injuries: A Qualitative Study [Letter]","authors":"Zhanshuo Xiao, Yilin Jiang, Narina A Samah","doi":"10.2147/ppa.s494075","DOIUrl":"https://doi.org/10.2147/ppa.s494075","url":null,"abstract":"Letter for the article Motivation and Barriers to Postoperative Rehabilitation Exercise in Type 2 Diabetic Patients with Rotator Cuff Injuries: A Qualitative Study","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"4 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142204071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acceptance of COVID-19 Vaccination and Vaccine Hesitancy Among People with Chronic Diseases in Thailand: Role of Attitudes and Vaccine Literacy Towards Future Implications 泰国慢性病患者对 COVID-19 疫苗接种的接受程度和疫苗接种犹豫:态度和疫苗知识对未来影响的作用
IF 2.2 3区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-05 DOI: 10.2147/ppa.s462014
Sirirat Leelacharas, Wantana Maneesriwongul, Nipaporn Butsing, Kamonrat Kittipimpanon, Poolsuk Janepanish Visudtibhan
Introduction: Vaccination is an important strategy to prevent or reduce hospitalizations and mortality caused by COVID-19 infection. However, some people with chronic diseases are hesitant to get the COVID-19 vaccination.
Objective: This study aimed to assess the acceptance of COVID-19 vaccination and associated factors among people with chronic diseases.
Methods: A cross-sectional online survey was conducted between May and August 2021. A sample of 457 Thai adults living with one or more chronic diseases was drawn from a larger online survey.
Results: Participants were 19 to 89 years old. The three most commonly reported chronic diseases were hypertension, diabetes, and obesity. The acceptance rate of COVID-19 vaccination was 89.1%. Forty-six percent of respondents had received the COVID-19 vaccination, and 43.1% intended to get the vaccine. Reasons for vaccine hesitancy/refusal included concerns about adverse side effects from the vaccines including long-term effects that might complicate their disease condition. Multiple logistic regression analyses revealed that having a bachelor’s degree or higher [aOR 4.40; 95% CI: 2.12– 9.14], being employed [aOR 2.11; 95% CI: 1.03– 4.39], and having positive attitudes [aOR 2.36; 95% CI: 1.69– 3.29] and negative attitudes [aOR 0.38; 95% CI: 0.27– 0.55] predicted acceptance of the COVID-19 vaccination. Vaccine literacy was significantly associated with acceptance of COVID-19 vaccination in binary logistic regression analyses, but it was not retained in the multiple logistic regression model.
Conclusion: Vaccine literacy and attitudes influence acceptance of COVID-19 vaccination in people with chronic diseases.

Keywords: COVID-19, vaccine, vaccine literacy, attitudes, acceptance of COVID-19 vaccination, chronic diseases, Thailand
导言:接种疫苗是预防或减少 COVID-19 感染导致的住院率和死亡率的重要策略。然而,一些慢性病患者对接种 COVID-19 疫苗犹豫不决:本研究旨在评估慢性病患者对 COVID-19 疫苗接种的接受程度及相关因素:方法:2021 年 5 月至 8 月期间进行了一项横断面在线调查。从一项更大规模的在线调查中抽取了 457 名患有一种或多种慢性疾病的泰国成年人作为样本:结果:参与者的年龄在 19 至 89 岁之间。最常报告的三种慢性病是高血压、糖尿病和肥胖症。COVID-19疫苗的接受率为89.1%。46%的受访者接种过 COVID-19 疫苗,43.1%的受访者打算接种该疫苗。犹豫/拒绝接种疫苗的原因包括担心疫苗的不良副作用,包括可能使病情复杂化的长期影响。多元逻辑回归分析表明,拥有学士学位或更高学历[aOR 4.40;95% CI:2.12- 9.14]、有工作[aOR 2.11;95% CI:1.03- 4.39]、态度积极[aOR 2.36;95% CI:1.69- 3.29]和态度消极[aOR 0.38;95% CI:0.27- 0.55]可预测是否接受 COVID-19 疫苗接种。在二元逻辑回归分析中,疫苗素养与COVID-19疫苗接种的接受度有明显相关性,但在多元逻辑回归模型中却没有被保留下来:结论:疫苗知识和态度影响慢性病患者对COVID-19疫苗接种的接受程度:COVID-19、疫苗、疫苗知识、态度、COVID-19疫苗接种接受度、慢性病、泰国
{"title":"Acceptance of COVID-19 Vaccination and Vaccine Hesitancy Among People with Chronic Diseases in Thailand: Role of Attitudes and Vaccine Literacy Towards Future Implications","authors":"Sirirat Leelacharas, Wantana Maneesriwongul, Nipaporn Butsing, Kamonrat Kittipimpanon, Poolsuk Janepanish Visudtibhan","doi":"10.2147/ppa.s462014","DOIUrl":"https://doi.org/10.2147/ppa.s462014","url":null,"abstract":"<strong>Introduction:</strong> Vaccination is an important strategy to prevent or reduce hospitalizations and mortality caused by COVID-19 infection. However, some people with chronic diseases are hesitant to get the COVID-19 vaccination.<br/><strong>Objective:</strong> This study aimed to assess the acceptance of COVID-19 vaccination and associated factors among people with chronic diseases.<br/><strong>Methods:</strong> A cross-sectional online survey was conducted between May and August 2021. A sample of 457 Thai adults living with one or more chronic diseases was drawn from a larger online survey.<br/><strong>Results:</strong> Participants were 19 to 89 years old. The three most commonly reported chronic diseases were hypertension, diabetes, and obesity. The acceptance rate of COVID-19 vaccination was 89.1%. Forty-six percent of respondents had received the COVID-19 vaccination, and 43.1% intended to get the vaccine. Reasons for vaccine hesitancy/refusal included concerns about adverse side effects from the vaccines including long-term effects that might complicate their disease condition. Multiple logistic regression analyses revealed that having a bachelor’s degree or higher [aOR 4.40; 95% CI: 2.12– 9.14], being employed [aOR 2.11; 95% CI: 1.03– 4.39], and having positive attitudes [aOR 2.36; 95% CI: 1.69– 3.29] and negative attitudes [aOR 0.38; 95% CI: 0.27– 0.55] predicted acceptance of the COVID-19 vaccination. Vaccine literacy was significantly associated with acceptance of COVID-19 vaccination in binary logistic regression analyses, but it was not retained in the multiple logistic regression model.<br/><strong>Conclusion:</strong> Vaccine literacy and attitudes influence acceptance of COVID-19 vaccination in people with chronic diseases.<br/><br/><strong>Keywords:</strong> COVID-19, vaccine, vaccine literacy, attitudes, acceptance of COVID-19 vaccination, chronic diseases, Thailand<br/>","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"7 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142204072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Patient preference and adherence
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1